BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8477155)

  • 1. Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660.
    Buckle DR; Arch JR; Bowring NE; Foster KA; Taylor JF; Taylor SG; Shaw DJ
    Pulm Pharmacol; 1993 Mar; 6(1):77-86. PubMed ID: 8477155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents.
    Berry JL; Small RC; Foster RW
    Br J Pharmacol; 1992 Aug; 106(4):813-8. PubMed ID: 1393280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil.
    Taylor SG; Arch JR; Bond J; Buckle DR; Shaw DJ; Taylor JF; Ward JS
    J Pharmacol Exp Ther; 1992 May; 261(2):429-37. PubMed ID: 1578358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glibenclamide blocks the relaxant action of pinacidil and cromakalim in airway smooth muscle.
    Nielsen-Kudsk JE; Bang L; Brønsgaard AM
    Eur J Pharmacol; 1990 May; 180(2-3):291-6. PubMed ID: 2114300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
    Eltze M
    Eur J Pharmacol; 1989 Jun; 165(2-3):231-9. PubMed ID: 2528466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate.
    Kuromaru O; Sakai K
    Clin Exp Pharmacol Physiol; 1996; 23(6-7):493-7. PubMed ID: 8800572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxant effects of BRL 38227 and pinacidil on the rat gastric fundus.
    Lefebvre RA; Horacek J
    Eur J Pharmacol; 1992 Apr; 214(1):1-6. PubMed ID: 1582448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cromakalim-induced relaxation of guinea-pig isolated trachealis: antagonism by glibenclamide and by phentolamine.
    Murray MA; Boyle JP; Small RC
    Br J Pharmacol; 1989 Nov; 98(3):865-74. PubMed ID: 2511995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a novel benzopyran derivative, KC 399, on the isolated guinea-pig trachealis and human bronchi.
    Imagawa J; Yoshida S; Koga T; Kamei K; Nabata H
    Gen Pharmacol; 1993 Nov; 24(6):1505-12. PubMed ID: 8112528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smooth muscle relaxation and inhibition of responses to pinacidil and cromakalim induced by phentolamine in guinea-pig isolated trachea.
    Bang L; Nielsen-Kudsk JE
    Eur J Pharmacol; 1992 Feb; 211(2):235-41. PubMed ID: 1612110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries.
    Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
    J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of SCA40 on human bronchi and on guinea pig main bronchi in vitro. Comparison with cromakalim.
    Naline E; Cui YY; Michel A; Bonnet PA; Bakdach H; Advenier C
    Fundam Clin Pharmacol; 1996; 10(4):368-78. PubMed ID: 8871136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antagonism by glibenclamide of the relaxant effects of cromakalim, pinacidil and nicorandil on canine large coronary arteries.
    Satoh K; Yamada H; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):76-82. PubMed ID: 1827660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro.
    Wilson C
    J Auton Pharmacol; 1989 Feb; 9(1):71-8. PubMed ID: 2498342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antidiabetic sulphonylureas, cromakalim and their interaction in guinea-pig isolated tracheal smooth muscle.
    Nielsen-Kudsk JE; Thirstrup S
    Pulm Pharmacol; 1993 Sep; 6(3):185-92. PubMed ID: 8219573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor.
    Jones TR; Charette L; Garcia ML; Kaczorowski GJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):697-706. PubMed ID: 1700817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional and species differences in glyburide-sensitive K+ channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim.
    Kamei K; Yoshida S; Imagawa J; Nabata H; Kuriyama H
    Br J Pharmacol; 1994 Nov; 113(3):889-97. PubMed ID: 7858882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.